Session 18-A

Operationalizing Generative AI at Gilead with the Gilead Enterprise Data & AI Platform

← Back to Agenda

Generative AI has the potential to revolutionize biopharmaceutical innovation and operations. At Gilead Sciences, the Gilead Enterprise Data & AI Platform serves as the foundational ecosystem for securely scaling data and AI solutions. This talk explores how Gilead operationalizes Generative AI, transforming initial prototypes into production-grade solutions through the platform’s robust infrastructure, including self-service AI workspaces, MLOps & LLMOps tooling, and comprehensive Responsible AI governance.

Key topics include the transformation from traditional MLOps to LLMOps, the integration of foundation models, prompt engineering, and vector databases, and the processes needed to scale from a compelling demo to a fully operational solution. Attendees will gain insights into Gilead’s strategies for AI risk assessment, real-time model monitoring, and fostering enterprise collaboration through a centralized AI agent catalog and federated governance.

By streamlining generative AI adoption, Gilead accelerates the delivery of impactful, enterprise-ready AI solutions, driving innovation to advance its mission of transforming care for patients worldwide.

Speaker

nghi ho

Senior Director, Head of Data & AI Platform and Enterprise Data Governance, Gilead Sciences